Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Jernberg

Showing results (251-260 of 345) with videos related to

Pageof 35
Sort By:
Journal of the American Heart Association|June 27, 2024
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART RegistryAnton Håkansson, Sasha Koul, Elmir Omerovic, et al.
European Heart Journal|December 28, 2020
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort studyJessica Schubert, Bertil Lindahl, Håkan Melhus, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Inotropes and mortality in patients with cardiogenic shock: an instrumental variable analysis from the SWEDEHEART registryPetur Petursson, Thorsteinn Gudmundsson, Truls Råmunddal, et al.
Journal of the American Heart Association|October 27, 2022
On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography StudyMoman A Mohammad, Gregg W Stone, Sasha Koul, et al.
Journal of Psychiatric Research|January 25, 2021
Risk of specific cardiovascular diseases in obsessive-compulsive disorderKayoko Isomura, Anna Sidorchuk, Gustaf Brander, et al.
Cardiovascular Research|July 28, 2019
Statistics on mortality following acute myocardial infarction in 842 897 EuropeansOras A Alabas, Tomas Jernberg, Mar Pujades-Rodriguez, et al.
Clinical Cardiology|August 8, 2021
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational studyEva Lesén, Christopher Hewitt, Evangelos Giannitsis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2016
Prevalence and recognition of chronic kidney disease in Stockholm healthcareAlessandro Gasparini, Marie Evans, Josef Coresh, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 19, 2021
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registriesRobert Edfors, Tomas Jernberg, Christian Lewinter, et al.
Journal of the American College of Cardiology|June 3, 2017
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular DysfunctionTatendashe B Dondo, Marlous Hall, Robert M West, et al.
Pageof 35

Showing results (251-260 of 345) with videos related to

Sort By:
Pageof 35
Journal of the American Heart Association|June 27, 2024
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART RegistryAnton Håkansson, Sasha Koul, Elmir Omerovic, et al.
European Heart Journal|December 28, 2020
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort studyJessica Schubert, Bertil Lindahl, Håkan Melhus, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Inotropes and mortality in patients with cardiogenic shock: an instrumental variable analysis from the SWEDEHEART registryPetur Petursson, Thorsteinn Gudmundsson, Truls Råmunddal, et al.
Journal of the American Heart Association|October 27, 2022
On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography StudyMoman A Mohammad, Gregg W Stone, Sasha Koul, et al.
Journal of Psychiatric Research|January 25, 2021
Risk of specific cardiovascular diseases in obsessive-compulsive disorderKayoko Isomura, Anna Sidorchuk, Gustaf Brander, et al.
Cardiovascular Research|July 28, 2019
Statistics on mortality following acute myocardial infarction in 842 897 EuropeansOras A Alabas, Tomas Jernberg, Mar Pujades-Rodriguez, et al.
Clinical Cardiology|August 8, 2021
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational studyEva Lesén, Christopher Hewitt, Evangelos Giannitsis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2016
Prevalence and recognition of chronic kidney disease in Stockholm healthcareAlessandro Gasparini, Marie Evans, Josef Coresh, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 19, 2021
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registriesRobert Edfors, Tomas Jernberg, Christian Lewinter, et al.
Journal of the American College of Cardiology|June 3, 2017
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular DysfunctionTatendashe B Dondo, Marlous Hall, Robert M West, et al.
Pageof 35